Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03268057
Title VX15/2503 in Combination With Avelumab in Advanced Non-small Cell Lung Cancer
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Vaccinex Inc.

lung non-small cell carcinoma


Avelumab + Pepinemab

Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Highlands Oncology Group, PA Fayetteville Arkansas 72703 United States Details
University of California Los Angeles (UCLA) Los Angeles California 90095 United States Details
Mayo Clinic Jacksonville Florida 32224 United States Details
Moffitt Cancer Center Tampa Florida 33612 United States Details
Mayo Clinic Rochester Minnesota 55905 United States Details
Washington University School of Medicine Saint Louis Missouri 63110 United States Details
Northwell Health Cancer Institute Lake Success New York 11042 United States Details
University of Rochester Rochester New York 14604 United States Details
Gabrail Cancer Center Canton Ohio 44718 United States Details
Providence Portland Medical Center Portland Oregon 97213 United States Details
Virginia Cancer Specialists, PC Fairfax Virginia 22031 United States Details
*Shaded cells indicate that there was no data available from for the field